Beta-blockers in the treatment of heart failure. CIBIS III Trial
Journal Title: Przewodnik Lekarza - Year 2005, Vol 82, Issue 10
Abstract
Heart failure is a very important problem in health care system. In Europe there are almost 10 millions and in Poland half a million patients with left ventricular dysfunction. Heart failure is a clinical disorder characterized by insufficient perfusion of peripheral tissues and fluid retention. Improvement of heart contractility is one of the major therapeutic aims among patients with left ventricular dysfunction. The exact knowledge of methods of heart assistance is indispensable in practice both cardiologist, cardiac surgeons and general practitioners. Beta-blockers are the most important medicines used in the treatment of heart failure. Each new clinical trial informs about the additional benefits resulting of their application. The similarly effect we have already observed during recent presentation of CIBIS III.
Authors and Affiliations
Maciej Banach, Marcin Barylski, Jarosław Drożdż
Keywords
Related Articles
- EP ID EP112777
- DOI -
- Views 81
- Downloads 0
The strategy of glaucoma treatment
The contemporary view on pathogenesis of different glaucoma types as well as the individual treatment approach was described in this paper. Modern diagnostic tests and their implementation in glaucoma follow-up was brief...
Status asthmaticus
In the article author presents status asthmaticus definition, diagnosis and therapy in adult patients.
Role of statins in the treatment of heart disease. Heart failure
Statins are the strongest hypolipeamic agents lowering cholesterol fraction LDL-C. Many clinical analyses proved that therapy with statins decreases the risk of coronary disease, death, stroke and arteriosclerosis of p...
Nadciśnienie – choroba cywilizacyjna – rozmowa z prof. Krzysztofem Narkiewiczem
The effect of characteristic of pulmonary delivery devices and drug formulation on lung deposition and efficacy of inhalant therapy
The pulmonary drug delivery shows numerous advantages over other routes of administration. The major advantage is the high drug concentration in the lungs and low concentration in serum. Consequently, the systemic side e...